Primary Biliary Cholangitis: Clinical Trials

6 trials for Primary Biliary Cholangitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 1 recruiting. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Unknown 5, Recruiting 1

Follow Primary Biliary Cholangitis: new trials by email Literature Review of Primary Biliary Cholangitis trials Research Report on Primary Biliary Cholangitis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule
Babaodan Capsule - Primary Biliary Cholangitis
Phase 4UnknownMei Han602024-04-252024-04-17
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
Cyclosporin A, Mycophenolate Mofetil - Hepatitis, Autoimmune, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital892021-06-162021-06-22
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
Ursodeoxycholic acid combined with total glucosides of paeony, Ursodeoxycholic acid only - Hepatitis, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital1372021-03-172021-03-24
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
Ursodeoxycholic acid, Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) - Hepatitis, Autoimmune, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital902020-11-012021-03-22
Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
ursodeoxycholic acid - Primary Biliary Cholangitis
Phase 4RecruitingPeking Union Medical College Hospital902020-01-212025-04-01
A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
18-22mg/kg/d Ursodeoxycholic, 13-15mg/kg/d Ursodeoxycholic - Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital402018-01-302018-05-03

Narrower conditions

Liver Cirrhosis, Biliary (6)  ·  Hepatitis, Autoimmune (2)  ·  Hepatitis (1)

Broader conditions

Bile Duct Diseases (6)  ·  Biliary Tract Diseases (6)  ·  Cholestasis (6)  ·  Cholestasis, Intrahepatic (6)  ·  Digestive System Diseases (6)  ·  Fibrosis (6)  ·  Liver Cirrhosis (6)  ·  Liver Diseases (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Autoimmune Diseases (2)  ·  Hepatitis (2)  ·  Hepatitis, Chronic (2)  ·  Immune System Diseases (2)

Interventions

Ursodeoxycholic Acid (2)  ·  Cyclosporine (1)  ·  Mycophenolic Acid (1)

Sponsors

West China Hospital (4)  ·  Mei Han (1)  ·  Peking Union Medical College Hospital (1)

Countries

China (5)

Top investigators

Li Yang, MD (2)  ·  Li Wang (1)